Objective: This study aimed to investigate the influence of sarcopenic obesity on anastomotic leak following elective colon resection for non-metastatic colon cancer. Secondary outcomes included overall morbidity, mortality and length of hospital stay. Methods: This retrospective observational study, conducted at a colorectal surgery referral centre, spanned from January 1, 2015, to January 1, 2020. A total of 544 consecutive patients who underwent elective colon resection were included in the analysis, excluding patients with rectal cancer, urgent surgery, absence of anastomosis, lack of imaging, multivisceral resections and synchronic tumours. Results: Postoperative complications were observed in 177 (32.3%) patients, with 51 (9.31%) classified as severe (Clavien-Dindo > II). Sarcopenic obesity was identified in 9.39% of the sample and emerged as an independent predictor of increased overall morbidity [OR 2.15 (1.14–3.69); p = 0.016] and 30-day mortality [OR 5.07 (1.22–20.93); p = 0.03] and was significantly associated with the development of anastomotic leak [OR 2.95 (1.41–6.18); p = 0.007]. Furthermore, it increased the risk of reoperation and was linked to a prolonged length of hospital stay. Conclusions: CT-measured sarcopenic obesity demonstrates a discernible correlation with an elevated risk of postoperative morbidity and mortality in the context of colon cancer surgery.
Introducción y objetivo:La infección por coronavirus (COVID-19) en pacientes intervenidos es causa de importante mortalidad postoperatoria, aunque su incidencia es variable. El objetivo primario fue evaluar la incidencia de COVID-19 en los pacientes intervenidos en nuestro Servicio de Cirugía General y Digestiva, durante el máximo impacto de la pandemia en España. El objetivo secundario fue evaluar la mortalidad perioperatoria y determinar los factores de riesgo para la infección por COVID-19.Material y métodos:Estudio observacional retrospectivo de pacientes consecutivos sometidos a Cirugía General y Digestiva con ingreso superior a 24 horas, del 1 de febrero de 2020 al 30 de abril de 2020 en un hospital terciario de Madrid, España.Resultados:Se analizaron 441 pacientes: 423 sin COVID-19 y 18 con COVID-19. Las características preoperatorias y operatorias fueron similares para ambos grupos, salvo por el grado ASA (American Society of Anesthesiologists).La incidencia de COVID-19 en los pacientes intervenidos fue del 4,1 %. La mortalidad postoperatoria fue elevada, del 22,2 % en pacientes con COVID‑19, frente a un 2,8 % en pacientes no COVID‑19 (p: 0,003). Los factores de riesgo para la infección por COVID-19 en los pacientes intervenidos fueron una estancia hospitalaria prolongada (OR: 1,035 [95 % CI: 1,007 ‑ 1,065]) y la reintervención quirúrgica (OR: 5,025 [95 % CI: 1,650 – 15,311]).Conclusión:Las intervenciones durante la pandemia de COVID-19 causaron una baja tasa de infección con elevada mortalidad postoperatoria. La intervención quirúrgica debe valorarse frente al riesgo adicional para el paciente en contextos de alta transmisión.
Objective: To evaluate the impact of body composition parameters, including specifically sarcopenic obesity (SO), on postoperative and oncological outcomes in patients undergoing radical cystectomy (RC) for bladder cancer, thereby addressing a paucity of data in this setting. Methods: A retrospective observational study was conducted in patients who underwent RC. Preoperative CT scans were analyzed using semi-automatic segmentation software to assess body composition parameters, with measurements of adipose and muscle tissue obtained at the level of the L3 vertebra. Results: A total of 249 patients were included, of whom 127 (52.5%) met the criteria for sarcopenia, 53 (21.3%) for obesity, and 14 (5.6%) for SO. Multivariate analysis identified previous abdominal surgery (OR 2.56, 95% CI 1.24–5.23, p = 0.011), total serum protein level (OR 0.57, 95% CI 0.36–0.88, p = 0.013), and SO (OR 7.01, 95% CI 1.06–37.05, p = 0.045) as independent predictors of 90-day postoperative complications. Patients with SO experienced significantly higher rates of abdominal wall complications (p = 0.03). However, in multivariate analyses, SO was not associated with overall survival (despite a p value of 0.04 at univariate analysis), cancer-specific survival, or progression-free survival. Conclusions: Preoperative CT-based assessment of body composition is a valuable tool in the surgical evaluation of patients undergoing RC. SO appears to be an independent predictor of short-term postoperative complications and should be considered when planning prehabilitation strategies.
Purpose to investigate the impact of sarcopenic obesity on anastomotic leak. Secondary outcomes included overall morbidity, mortality and length of hospital stay. Methods This was a unicenter, retrospective observational study conducted from January 1, 2015 to January 1, 2020. Conducted in a colorectal surgery referral center. A total of 544 consecutive patients who underwent elective colonic resection for non-metastatic colon cancer. Exclusion criteria included rectal cancer, urgent surgery, lack of anastomosis, lack of imaging, multivisceral resections and synchronic tumors. Results A total of 544 patients were included in the analysis with a mean age of 72.6 ± 10.8 years. Complications were noted in 177 (32.3%) patients, of which 51 (9.31%) were severe (Clavien Dindo > II). Sarcopenic obesity was seen in 24.8% of the sample, which was an independent indicator of increased overall morbidity (OR = 1.71, 95% CI: 1.14–2.56, p 0.009), a predictor of 30-day mortality (OR = 6.29, 95% CI: 1.55–25.53, p 0.010) and was significantly associated with development of anastomotic leak (OR = 1.42, 95% CI: 1.05–1.92, p 0.024). Additionally, it increased the risk of reoperation and was related to a prolonged length of hospital stay. Conclusions CT-measured sarcopenic obesity is associated with an increased risk of postoperative morbidity and mortality in colon cancer surgery.